Stephan Morris
Hematology & Oncology
Credentials: · ·
History
Hematology and Medical Oncology
Internal Medicine
Research
Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma
Science · 1994 · First of 7 authors · 1,941 citations
Activating mutations in ALK provide a therapeutic target in neuroblastoma
Nature · 2008 · 709 citations
Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction
American Journal of Respiratory Cell and Molecular Biology · 2012 · 429 citations
10 papers · 4 as a resident
James Downing
6 papers
- FE
5 papers
4 papers
4 papers
- PM
4 papers
3 papers
- JS
3 papers
Grants
- 2020–2022
Efficacy of a Novel Small-Molecule Splicing Modulator in Chronic Lymphocytic Leukemia (CLL)
National Cancer Institute · R41
PI · $400K · Wildflower Biopharma Inc
- 2018–2020
Development of a Novel Clinical Diagnostic Assay for Peripheral T-Cell Lymphoma (PTCL)
National Cancer Institute · R41
Contact PI · $299.4K · Healthchart, Llc
- 1996–2009
NPM-ALK and ALK in Lymphoma and Normal Development
National Cancer Institute · R01
Contact PI · $3.1M · St. Jude Children's Research Hospital
- 2004–2006
Development of Novel Therapies for Pediatric Cancer
National Cancer Institute · U56
Contact PI · $75K · St. Jude Children's Research Hospital